NDC 70114-440 – Cimerli
Ranibizumab .3 mg/.05mL · Injection, Solution · Intravitreal
Product NDC70114-440
Product details
- Brand name
- Cimerli
- Generic name
- ranibizumab-eqrn
- Labeler
- Coherus BioSciences Inc
- Dosage form
- Injection, Solution
- Route
- Intravitreal
- Marketing category
- BLA · BLA761165
- Marketed since
- October 3, 2022
- Marketing end
- January 31, 2027
- Pharmacologic class
- Vascular Endothelial Growth Factor Inhibitor
Active ingredients
- Ranibizumab .3 mg/.05mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 70114-440-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70114-440-01) / .05 mL in 1 VIAL, SINGLE-DOSE | Oct 3, 2022 |